Skip to content
‹ Back to IndustriesSciences

Elon Musk Successfully Launches the Falcon Heavy Rocket

Elon Musk has made it his life mission to take humankind to space. On February 6th, he got even closer to achieving that goal when his company SpaceX launched the historic maiden voyage of its Falcon Heavy Rocket, putting a Tesla Roadster into orbit, and landing two rocket boosters back on Earth. After a brief…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Promoted Content
Share
Elon Musk Successfully Launches the Falcon Heavy Rocket

Key takeaways

01

Elon Musk has made it his life mission to take humankind to space.

02

On February 6th, he got even closer to achieving that goal when his company SpaceX launched the historic maiden voyage of its Falcon Heavy Rocket, putting a Tesla Roadster into orbit, and landing two rocket boosters back on Earth.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Try it Free

Elon Musk has made it his life mission to take humankind to space. On February 6th, he got even closer to achieving that goal when his company SpaceX launched the historic maiden voyage of its Falcon Heavy Rocket, putting a Tesla Roadster into orbit, and landing two rocket boosters back on Earth. After a brief two-hour delay, the launch departed from Kennedy Space Center in Cape Canaveral, Florida—the same location from which NASA’s Apollo moon missions and space shuttles departed from.

The rocket itself is impressive. It stands at a massive 23 stories tall and is powered by 27 engines on three core boosters, which produces 5 million lbs. of thrust at liftoff. SpaceX, ever the innovator in composite applications, engineered the rocket’s payload fairing with a composite structure and carbon fiber face sheets that were manufactured in-house. It’s built to protect satellites during delivery to low-Earth orbit as well as geosynchronous transfer orbit.

That Tesla Roadster is something to see as well. Equipped with a mannequin named “Starman” after the 1972 David Bowie song, and a dashboard message of “Don’t Panic!” from the book Hitchhiker’s Guide to the Galaxy by Douglas Adams, the cherry red convertible is currently on a trajectory taking it past Mars, and on its way to orbit the sun. You can watch footage of it here.

After the success of the launch, two of the core boosters, designed to be reusable, returned to their designated areas in Cape Canaveral Air Force Station. The third was set to land on a landing pad in the Atlantic Ocean. It missed—taking out a drone ship nearby, and plunging into the water at 300 miles per hour. Despite this miscalculation, the test run was still a huge success for the future of space exploration and space travel.

“I think it’s going to open up a sense of possibility,” Musk was widely reported to have said after the launch. “We want a new space race. Space races are exciting.”

SpaceX is ready to lead the charge. With the success of the test run, the next steps include commercial satellite launches for the U.S. Air Force and a solar-sail mission for The Planetary Society. After that, SpaceX wants to send people to Mars as early as 2024.

“Crazy things can come true,” Musk added. “When I see a rocket lift off, I see a thousand things that could not work, and it’s amazing when they do.” Some of those amazing things working where they shouldn’t are undoubtedly because of the use of composites.

Magnum Venus Products is an innovator of composites, pumping and spraying equipment for closed/open molds, adhesives, and epoxies. MVP serves a multitude of manufacturers in a variety of industries such as automotive, aerospace, transportation, marine, railway, and oil & gas among many others. For more information on the great products MVP offers, visit the website!

Read more at mvpind.com

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512